Back to News
investment
Eli Lilly-Backed Aktis Jumps 50% After $318 Million US IPO
Bloomberg Markets
Loading...
1 min read
3 views
0 likes
Summarize this article with:
Aktis Oncology Inc. shares jumped 50% in their trading debut after the clinical-stage biotechnology company raised $317.7 million in an initial public offering.
Source Information
Source: Bloomberg Markets